Tim Clarkson's Title

Tim Clarkson serves as a board member at Recombinetics, a pioneering company in the field of genetic engineering. His role on the board involves strategic decision-making, oversight of corporate governance, and contributing to the company's long-term vision. Tim's expertise in navigating complex regulatory environments and his deep understanding of biotechnology make him a valuable asset to Recombinetics.

Tim Clarkson's Company

Recombinetics is a leading biotechnology firm specializing in genetic engineering and gene editing solutions. The company focuses on developing innovative therapies and improving livestock genetics to enhance health outcomes and agricultural productivity. With Tim Clarkson on its board, Recombinetics benefits from his strategic insights and industry know-how, which are crucial for advancing their cutting-edge research and commercial applications.

Tim Clarkson's Expertise

As a board member of Recombinetics, Tim Clarkson brings a wealth of expertise in biotechnology and genetic engineering. His proficiency in these areas allows him to provide invaluable guidance on regulatory compliance, ethical considerations, and strategic partnerships. Tim's adeptness at steering high-level discussions on scientific advancements ensures that Recombinetics stays at the forefront of innovation in genetic technologies.

Tim Clarkson's Achievements

Tim Clarkson has achieved significant milestones in his career, particularly in the biotechnology sector. His contributions to Recombinetics have helped the company secure key regulatory approvals and forge strategic alliances with industry leaders. Tim's ability to navigate complex scientific and regulatory landscapes has been instrumental in positioning Recombinetics as a trailblazer in genetic engineering.

report flag Report inaccurate information

People similar to Tim Clarkson

R.J. Cody Markelz

Co-Founder, VP Genomics @ Rev Genomics

R.J. Cody Markelz is a co-founder and the Vice President of Genomics, specializing in plant systems biology with a focus on physiology, growth, statistics, and quantitative genomics.

Rocco Morelli

Chief Executive Officer @ Recombinetics

Adrienne Watson, Ph.D.

Chief Science Officer | Therillume @ Recombinetics